NDAORALFOR SOLUTIONPriority Review
Approved
Jan 2018
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
4/8 — Partial
Priority Review
FIRVANQ KIT (vancomycin hydrochloride) by R-Pharm US is [ see microbiology ( ) ]. First approved in 2018.
Drug data last refreshed 18m ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FIRVANQ KIT is an oral vancomycin hydrochloride solution approved in 2018 for treating Clostridioides difficile infections. Vancomycin is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala peptidoglycan precursors. The oral formulation is specifically designed for local GI tract delivery to treat CDI.
Peak8.7 years to LOE
Product is at peak commercial stage with established market presence, suggesting stable team size and focus on market maintenance rather than launch infrastructure.
Mechanism of Action
[ see Microbiology ( ) ].
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
FIRVANQ KIT offers career opportunities primarily in commercial and medical affairs functions supporting a niche specialty pharmaceutical product with stable market dynamics. Working on this product positions you in a focused therapeutic area (infectious disease/CDI) with established competitive advantages but limited growth runway before patent expiration.
Brand ManagerField Sales Representative
Worked on FIRVANQ KIT at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.